Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
50,219.52
+431.58(+0.87%)

'We sold £1.5m of product sold in first week'

Lyma founder on rise of her wellness company

Biomea Fusion, Inc. (BMEA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

10.78

+0.31

(+2.96%)

At close: 04:00PM EDT

10.78

0.00

(0.00%)

After hours:

05:37PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	386.89M
Enterprise value	220.32M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	2.29
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-1.77

Trading information

Stock price history

Beta (5Y monthly)	-0.54
52-week change ³	-66.00%
S&P500 52-week change ³	22.36%
52-week high ³	43.69
52-week low ³	8.12
50-day moving average ³	14.77
200-day moving average ³	14.99

Share statistics

Avg vol (3-month) ³	1.04M
Avg vol (10-day) ³	835.01k
Shares outstanding ⁵	35.89M
Implied shares outstanding ⁶	35.89M
Float ⁸	19.38M
% held by insiders ¹	25.18%
% held by institutions ¹	87.14%
Shares short (15 Apr 2024) ⁴	13.82M
Short ratio (15 Apr 2024) ⁴	10.91
Short % of float (15 Apr 2024) ⁴	70.56%
Short % of shares outstanding (15 Apr 2024) ⁴	38.50%
Shares short (prior month 15 Mar 2024) ⁴	11.2M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-47.89%
Return on equity (ttm)	-84.42%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-124.62M
Net income avi to common (ttm)	-117.25M
Diluted EPS (ttm)	-3.44
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	176.87M
Total cash per share (mrq)	4.93
Total debt (mrq)	10.3M
Total debt/equity (mrq)	6.08%
Current ratio (mrq)	7.84
Book value per share (mrq)	4.72

Cash flow statement

Operating cash flow (ttm)	-96.59M
Levered free cash flow (ttm)	-62.19M